Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Faster 3D Nanoimaging with Full Color Synchrotron Light Under Development

By BiotechDaily International staff writers
Posted on 27 Jul 2011
Researchers can now see objects more completely and faster at the nanoscale level due to utilizing the full spectrum of synchrotron light, creating avenues for faster three-dimensional (3D) nanoimaging. This new methodology will provide for enhanced nanoimaging for examining biosamples for medical research, improved drug development, and advanced materials for engineering.

Using the Advanced Photon Source at Argonne National Laboratory (Argonne, IL, USA), researchers from the ARC Center of Excellence for Coherent X-ray Science (CXS), headquartered at the University of Melbourne, Australia, revealed that by utilizing the full spectrum of colors of the synchrotron, they increased the clarity of biologic samples and obtained a 60-fold increase in the speed of imaging.

Prof. Keith Nugent, a professor of physics at the University of Melbourne and research director of CXS, said the discovery was an exciting development. “Typically for best imaging, researchers need to convert samples to crystals, but this is not always possible in all samples,” he said. “This discovery of utilizing full color synchrotron light to improve precision and speed of imaging has huge potential in the field.”

The international project was led by Dr. Brian Abbey of the University of Melbourne’s School of Physics and CXS, whose team made the discovery. “We will now be able to see things in detail at the nanoscale much more easily. It is like going from an old film camera to the latest digital SLR. The increase in speed, in particular, opens the way for us to see things faster in 3D at the nanoscale, which has previously taken an impracticably long time,” Dr. Abbey said.

The study was published in the July 2011 issue of the journal Nature Photonics.

Related Links:
Advanced Photon Source
ARC Center of Excellence for Coherent X-ray Science



Channels

Genomics/Proteomics

view channel
Image: Photomicrograph showing acute myeloid leukemia (AML) cells (Photo courtesy of the University of California, San Diego).

Cell Surface Protein Deletion Blocks AML Growth in Mouse Model

Cancer researchers have found that the cell surface protein tetraspanin3 (Tspan3) is required for the development and propagation of the fast-growing and extremely difficult-to-treat blood cancer, acute... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.